REDX — Redx Pharma Share News
0.000.00%
- £35.01m
- £34.60m
- £4.20m
Share Purchases by PDMR’s
Update on AIM Delisting
TR-1: Notification of major holdings
Share Purchases by a Director
Share Purchase by a Director
TR-1: Notification of major holdings
Brief: Redx Pharma Announces Re-Registration As Private Limited Co
Redx to Present at Cowen Health Care Conference
New Grant of Options
Notice of AGM
Brief: Redx Pharma Says Currently Not In Any Process Relating To A Listing In U.S.
Statement re Press Report
TR-1: Notification of major holdings
Brief: Redx Pharma Sells KRAS Inhibitor Program
Brief: Jazz Pharmaceuticals Enters Definitive Agreement With Redx Pharma To Acquire Global Rights To KRAS Inhibitor Program
Brief: Jazz Pharmaceuticals Enters Agreement With Redx Pharma To Acquire Global Rights To Kras Inhibitor Program
Redx announces sale of KRAS inhibitor program
Brief: Redx Pharma PLC Says Loss For FY Period Of £33.2 Mln
Final Audited Results for Year Ended 30 September